Head-To-Head Comparison: Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT)

Definitive Healthcare (NASDAQ:DH – Get Free Report) and Certara (NASDAQ:CERT – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Insider and Institutional Ownership

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Definitive Healthcare and Certara’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Definitive Healthcare -69.18% 4.35% 1.84%
Certara -16.14% 3.36% 2.31%

Valuation and Earnings

This table compares Definitive Healthcare and Certara”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Definitive Healthcare $241.52 million 0.57 -$138.93 million ($1.50) -0.85
Certara $425.76 million 4.20 -$1.60 million ($0.42) -27.93

Certara has higher revenue and earnings than Definitive Healthcare. Certara is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Definitive Healthcare has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, Certara has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Definitive Healthcare and Certara, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare 3 6 0 0 1.67
Certara 1 7 4 1 2.38

Definitive Healthcare currently has a consensus target price of $1.47, suggesting a potential upside of 14.96%. Certara has a consensus target price of $9.92, suggesting a potential downside of 15.46%. Given Definitive Healthcare’s higher possible upside, research analysts plainly believe Definitive Healthcare is more favorable than Certara.

Summary

Certara beats Definitive Healthcare on 9 of the 15 factors compared between the two stocks.

About Definitive Healthcare

(Get Free Report)

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions. The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

About Certara

(Get Free Report)

Certara provides software and consulting services that support the development and use of medicines. Its biosimulation tools help pharmaceutical and biotechnology companies model how drugs behave in the body, assess potential treatment outcomes, and inform decisions during drug research and development. The company’s offerings include software for pharmacokinetic and pharmacodynamic modeling, clinical trial simulation, and drug development analysis. Certara also provides scientific and regulatory consulting, including support for regulatory submissions and strategies that use modeling and simulation to guide development programs.

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.